Deadline: March 11. 2022, by 5:00 p. m.
Precision medicine is defined as an “approach for disease prevention and treatment that takes into account individual differences in lifestyle, environment, and biology.” Precision public health is defined as “improving the ability to prevent disease, promote health, and reduce health disparities in populations by: 1) applying emerging methods and technologies for measuring disease, pathogens, exposures, behaviors, and susceptibility in populations; and 2) developing policies and targeted implementation programs to improve health.” Precision public health projects should focus on using data to create and/or evaluate change in health outcomes.
Pilot Projects may involve interventions or any combination of multisource data, including but not limited to molecular (e.g., genomics, metabolomics, proteomics); imaging (e.g., MRI, pathology slides, dermatology images); patient-generated (e.g., mobile health devices, apps); clinical (e.g., electronic health records, devices, insurance claims); public health surveillance; social determinants of health; economic; or environmental. Projects are encouraged to incorporate artificial intelligence methods.